When can we expect onglyza's generic availability?

There isn’t a single fixed date. Generic availability for Onglyza (saxagliptin) depends on patent protection and regulatory approvals in your country, plus any court settlements or patent term extensions.

In the US, as of now there isn’t a generic Onglyza on the market, and the timeline for a generic entry is uncertain and can be pushed back by patent issues. Other countries vary similarly based on local patent status.

If you’d like, tell me your country (and whether you want US-specific or EU/UK info), and I can summarize the current status and the most relevant patent expiry dates or approvals. I can also guide you on how to check this yourself in official sources (like the FDA Orange Book or EU patent databases).